NCT06040073

Brief Summary

The present study sought to explore the predictive value of radial wall strain (RWS, derived solely from angiograms) for coronary artery lesion progression compared with lesion vulnerability assessed by optical coherence tomography (OCT). The lesion progression at 1 year was defined as an increase of ≥20% in diameter stenosis based on quantitative coronary angiography (QCA) evaluation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Jul 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jul 2024Dec 2026

First Submitted

Initial submission to the registry

September 3, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 15, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

July 7, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

November 6, 2024

Status Verified

November 1, 2024

Enrollment Period

12 months

First QC Date

September 3, 2023

Last Update Submit

November 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lesion progression assessed by QCA

    Defined as an increase of ≥20% in diameter stenosis based on QCA evaluation

    1 year

Secondary Outcomes (13)

  • Incidence of major adverse cardiac events (MACE)

    1 year, 2 years, 3 years

  • Incidence of all-cause death

    1 year, 2 years, 3 years

  • Incidence of new myocardial infarction

    1 year, 2 years, 3 years

  • Incidence of unplanned revascularization

    1 year, 2 years, 3 years

  • Incidence of stent thrombosis

    1 year, 2 years, 3 years

  • +8 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult study participants with acute myocardial infarction complicated by multi-vessel coronary artery diseases within 45 days.

You may qualify if:

  • Age ≥18 years
  • Acute myocardial infarction ≤ 45 days
  • Planned coronary angiography examination or potential interventional treatment
  • The presence of at least 1 non-flow-restricting lesion (visually estimated diameter stenosis: 30%-80%; QFR \> 0.80) in any non-infarct related artery with RVD ≥2.5 mm by visual assessment

You may not qualify if:

  • Cardiogenic shock
  • Pregnant or woman of child-bearing potential
  • Life expectancy less than 1 year for non-cardiac causes
  • Unable to tolerate contrast agents or anticoagulant/antiplatelet therapy
  • Prior CABG or planned CABG
  • Poor angiographic image quality precluding vessel contour detection or with suboptimal contrast opacification, branch ostium cannot be shown clearly, severe overlap in the stenosed segment or severe tortuosity of any interrogated vessel deemed not amenable to QFR or RWS measurement
  • An interrogated lesion require surgical bypass grafting
  • Unable to judge culprit lesion or infarct-related artery according to current evidence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lei Song

Beijing, 100037, China

RECRUITING

Related Publications (1)

  • Jiang Y, Sun Z, Yu B, Liu W, Gao H, Li J, Jin Z, Yu H, Zheng B, Guan C, Zhang H, Zhang Y, Gao L, Cui C, Song Y, Xu J, Dou K, Yang W, Qian J, Wu Y, Song L. Natural history of coronary atherosclerosis based on multimodal imaging and physiological fusion techniques: study protocol and rationale for the NASCENT study. BMJ Open. 2025 Oct 23;15(10):e105796. doi: 10.1136/bmjopen-2025-105796.

Study Officials

  • Lei Song, MD

    Chinese Academy of Medical Sciences, Fuwai Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Coronary Heart Disease Ward, First Section

Study Record Dates

First Submitted

September 3, 2023

First Posted

September 15, 2023

Study Start

July 7, 2024

Primary Completion

June 30, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

November 6, 2024

Record last verified: 2024-11

Locations